Literature DB >> 21181413

The many faces of atypical Ewing's sarcoma. A true entity mimicking sarcomas, carcinomas and lymphomas.

Isidro Machado1, Rosa Noguera, Eduardo Alcaraz Mateos, Silvia Calabuig-Fariñas, F Ignacio Aranda López, Antonio Martínez, Samuel Navarro, Antonio Llombart-Bosch.   

Abstract

Ewing's sarcoma family of tumours (ESFT) comprises a group of small round cell tumours (SRCT) genetically defined by specific chromosomal translocations resulting in a fusion of the EWSR1 gene with a member of the ETS family of transcription factors. Atypical ESFT are the most challenging of the ESFT subtypes, and the differential diagnosis with other SRCT of bone and soft tissue is difficult since these subtypes can resemble other neoplasms. The present article describes nine cases of genetically confirmed, atypical ESFT, having unusual alterations at morphological and immunohistochemical (IHC) levels associated with atypical clinical presentation mimicking sarcomas, carcinomas and lymphomas. Present results demonstrate that ESFT showing overlapping morphological and immunohistochemical features with other SRCT of soft tissue and bone, or even with carcinomas or lymphoma, can be differentiated using molecular techniques. In SRCT with EWSR1 translocation demonstrated by FISH, the RT-PCR analysis of specific sarcoma-related gene fusion can offer important clues for the diagnosis of specific entities, especially in tumours with unusual histopathology and/or IHC findings. Thus, we confirm that the integration of clinical, histopathological, IHC and genetic data becomes decisive in the diagnosis of bone and soft tissue sarcomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181413     DOI: 10.1007/s00428-010-1023-4

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  36 in total

1.  Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction.

Authors:  D C Mangham; A Williams; D J McMullan; J McClure; V P Sumathi; R J Grimer; A M Davies
Journal:  Histopathology       Date:  2006-03       Impact factor: 5.087

2.  The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.

Authors:  Károly Szuhai; Marije Ijszenga; Danielle de Jong; Apollon Karseladze; Hans J Tanke; Pancras C W Hogendoorn
Journal:  Clin Cancer Res       Date:  2009-03-24       Impact factor: 12.531

3.  Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

Authors:  Andrew L Folpe; John R Goldblum; Brian P Rubin; Bahig M Shehata; Wendy Liu; Angelo P Dei Tos; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-08       Impact factor: 6.394

4.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

5.  Superficial primitive Ewing's sarcoma: a clinicopathologic and molecular cytogenetic analysis of 14 cases.

Authors:  Marie J Terrier-Lacombe; Louis Guillou; Frédéric Chibon; Gabrielle Gallagher; Jean Benhattar; Philippe Terrier; Dominique Ranchère; Jean-Michel Coindre
Journal:  Mod Pathol       Date:  2008-09-26       Impact factor: 7.842

Review 6.  Soft tissue tumors associated with EWSR1 translocation.

Authors:  Salvatore Romeo; Angelo P Dei Tos
Journal:  Virchows Arch       Date:  2010-02       Impact factor: 4.064

7.  t(19;22)(q13;q12) Translocation leading to the novel fusion gene EWSR1-ZNF444 in soft tissue myoepithelial carcinoma.

Authors:  Petter Brandal; Ioannis Panagopoulos; Bodil Bjerkehagen; Sverre Heim
Journal:  Genes Chromosomes Cancer       Date:  2009-12       Impact factor: 5.006

8.  Periosteal Ewing-like adamantinoma.

Authors:  M Fukunaga; S Ushigome
Journal:  Virchows Arch       Date:  1998-10       Impact factor: 4.064

9.  Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns.

Authors:  N G Ordóñez
Journal:  Am J Surg Pathol       Date:  1998-11       Impact factor: 6.394

Review 10.  Small cell tumors of bone.

Authors:  Shaoying Li; Gene P Siegal
Journal:  Adv Anat Pathol       Date:  2010-01       Impact factor: 3.875

View more
  7 in total

1.  Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours.

Authors:  Isidro Machado; Samuel Navarro; Jose A López-Guerrero; Marco Alberghini; Piero Picci; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2011-09-02       Impact factor: 4.064

Review 2.  Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors.

Authors:  Maria Tsokos; Rita D Alaggio; Louis P Dehner; Paul S Dickman
Journal:  Pediatr Dev Pathol       Date:  2012

Review 3.  Bone- and cartilage-forming tumors and ewing sarcoma: an update with a gnathic emphasis.

Authors:  Brian D Stewart; John D Reith; Jacquelyn A Knapik; Angela C Chi
Journal:  Head Neck Pathol       Date:  2014-11-20

4.  The 1H, 15N and 13C resonance assignments of the low-complexity domain from the oncogenic fusion protein EWS-FLI1.

Authors:  Courtney N Johnson; Xiaoping Xu; Stephen P Holloway; David S Libich
Journal:  Biomol NMR Assign       Date:  2022-01-07       Impact factor: 0.731

5.  Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis.

Authors:  Isidro Machado; Julia Cruz; Javier Lavernia; Luis Rubio; Jorge Campos; María Barrios; Camille Grison; Virginie Chene; Gaelle Pierron; Olivier Delattre; Antonio Llombart-Bosch
Journal:  Virchows Arch       Date:  2013-11-10       Impact factor: 4.064

6.  Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.

Authors:  Nathan D Seligson; Richard D Maradiaga; Colin M Stets; Howard M Katzenstein; Sherri Z Millis; Alan Rogers; John L Hays; James L Chen
Journal:  NPJ Precis Oncol       Date:  2021-05-21

7.  Changing histopathological diagnostics by genome-based tumor classification.

Authors:  Michael Kloth; Reinhard Buettner
Journal:  Genes (Basel)       Date:  2014-05-28       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.